isoborneol has been researched along with Apoplexy in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, J; Lu, J; Ruan, M; Song, X; Wang, X; Xing, W; Yu, B; Zhang, X | 1 |
| Chen, X; Wang, W; Wang, Y; Zhao, W; Zhong, J | 1 |
| Chang, RC; Chen, ZX; Shan, CS; Shi, YH; Wang, Y; Xu, QQ; Zheng, GQ | 1 |
| Bai, J; Cao, YF; Du, Q; Du, SY; Guo, YW; Lu, Y; Xu, P | 1 |
| Bai, J; Du, SY; Guo, QL; Li, Y; Lu, Y; Xu, P | 1 |
| Gao, LY; Hua, Y; Liao, GY; Luo, CX; Sun, WX; Tang, Y; Wu, HY; Yang, SB; Zhang, ZP; Zhou, QG; Zhu, DY | 1 |
| Bai, J; Du, S; Li, P; Lu, Y; Wen, R; Xu, P; Zhang, Q | 1 |
| Choi, H; Kim, H; Kim, JH; Kim, KB; Ku, HY; Lee, CH; Lee, HS; Liu, KH; Moon, JK; Park, BS; Park, SJ; Shin, JG; Yea, SS | 1 |
1 review(s) available for isoborneol and Apoplexy
| Article | Year |
|---|---|
Borneol for Regulating the Permeability of the Blood-Brain Barrier in Experimental Ischemic Stroke: Preclinical Evidence and Possible Mechanism.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Camphanes; Humans; Male; Rats; Stroke | 2019 |
1 trial(s) available for isoborneol and Apoplexy
| Article | Year |
|---|---|
Pharmacokinetics, pharmacodynamics, safety, tolerability, and mass balance of single and continuous intravenous infusion of SPT-07A in healthy volunteers.
Topics: Adult; Camphanes; Double-Blind Method; Healthy Volunteers; Humans; Infusions, Intravenous; Stroke | 2020 |
6 other study(ies) available for isoborneol and Apoplexy
| Article | Year |
|---|---|
Exploring the synergic mechanism of Ligusticum striatum DC. and borneol in attenuating BMECs injury and maintaining tight junctions against cerebral ischaemia based on the HIF-1α/VEGF signalling pathway.
Topics: Animals; bcl-2-Associated X Protein; Blood-Brain Barrier; Brain Ischemia; Caspase 3; Claudin-5; Endothelial Cells; Glucose; Ligusticum; Mice; Occludin; Proto-Oncogene Proteins c-bcl-2; Stroke; Tight Junction Proteins; Tight Junctions; Vascular Endothelial Growth Factor A | 2023 |
The effect of stroke and other components in Xing-Nao-Jing on the pharmacokinetics of geniposide.
Topics: Animals; Area Under Curve; Camphanes; Chromatography, High Pressure Liquid; Disease Models, Animal; Drugs, Chinese Herbal; Gardenia; Iridoids; Male; Models, Biological; Rats; Rats, Sprague-Dawley; Stroke | 2014 |
[Comparative pharmacokinetic studies of borneol in brain and plasma of stroke or sham-operated rats after administration of Xingnaojing].
Topics: Administration, Oral; Animals; Brain; Camphanes; Drugs, Chinese Herbal; Humans; Male; Plasma; Stroke | 2013 |
The synergetic effect of edaravone and borneol in the rat model of ischemic stroke.
Topics: Animals; Anti-Inflammatory Agents; Antipyrine; Brain; Brain Ischemia; Camphanes; Cell Survival; Cells, Cultured; Coculture Techniques; Cyclooxygenase 2; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Edaravone; Free Radical Scavengers; Interleukin-1beta; Maze Learning; Neuroglia; Neurons; Rats, Sprague-Dawley; Stroke; Tumor Necrosis Factor-alpha | 2014 |
Xingnaojing mPEG2000-PLA modified microemulsion for transnasal delivery: pharmacokinetic and brain-targeting evaluation.
Topics: Administration, Intranasal; Animals; Biological Availability; Brain; Camphanes; Drug Delivery Systems; Drugs, Chinese Herbal; Emulsions; Iridoids; Male; Mice; Mice, Inbred ICR; Nasal Cavity; Polyesters; Polyethylene Glycols; Stroke | 2016 |
Identification and characterization of potent CYP2B6 inhibitors in Woohwangcheongsimwon suspension, an herbal preparation used in the treatment and prevention of apoplexy in Korea and China.
Topics: Aryl Hydrocarbon Hydroxylases; Camphanes; China; Cytochrome P-450 CYP2B6; Herb-Drug Interactions; Humans; Korea; Microsomes, Liver; Mixed Function Oxygenases; Oxidoreductases, N-Demethylating; Phytotherapy; Plant Preparations; Stroke; Suspensions | 2008 |